UNIVERSITE LOUIS PASTEUR
41Patents
13Active
41Granted
45Portfolio score
Filing activity: Apr 9, 1986 → Feb 2, 2010 · 13 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6093873A | Genetically engineered mice containing alterations in the gene encoding RXR | Human Necessities | 45 | Expired |
| US5589501A | Pharmaceutical compounds | Chemistry; Metallurgy | 42 | Expired |
| US7057151B2 | Optical transmission apparatus with directionality and divergence control | Physics | 30 | Expired |
| US7067133B2 | Methods and compositions for diseases associated with amyloidosis | Chemistry; Metallurgy | 30 | Expired |
| US7988861B2 | Materials based on tangled nanotubes or nanofibres, preparation method thereof and use of same | Chemistry; Metallurgy | 28 | Active |
| US6635429B1 | Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof | Chemistry; Metallurgy | 27 | Expired |
| US5644065A | Genetically engineered mice containing alterations in the MHC class II genes | Chemistry; Metallurgy | 23 | Expired |
| US6653322B1 | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | Human Necessities | 22 | Expired |
| US6130230A | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | Human Necessities | 16 | Expired |
| US5981218A | Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides | Chemistry; Metallurgy | 16 | Expired |
| US6716835B1 | Use of diltiazem for treating retinal pathologies | Human Necessities | 9 | Expired |
| US5484726A | Antibodies specific for human stromelysin-3 and a method for detection of stromelysin-3 | Human Necessities | 8 | Expired |
| US4931471A | Amides of paramethoxycinnamic and utilization thereof as solar filters | Chemistry; Metallurgy | 7 | Expired |
| US6031149A | Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins | Human Necessities | 6 | Expired |
| US6624154B1 | Compositions and methods for treatment of hyperproliferative diseases | Human Necessities | 5 | Expired |
| US7441955B2 | Radio-transparent real-time dosimeter for interventional radiological procedures | Physics | 5 | Expired |
| US6146835A | Human kappa opioid receptor, nucleic acids and uses thereof | Human Necessities | 5 | Expired |
| US6030794A | Genetically engineered mice and cell lines containing alterations in the genes encoding retinoic acid receptor and retinoid X receptor proteins | Human Necessities | 4 | Expired |
| US4791217A | Sulphur derivatives of para-methoxycinnamic acid, processes for their production, dermo-pharmaceutical and cosmetic compositions containing them and applications | Mechanical Engineering; Lighting; Heating | 4 | Expired |
| US8351123B2 | Diffractive head-up display device provided with a device for adjusting the position of the virtual image | Physics | 3 | Active |
| US7517587B2 | Macromolecules auto-assembled and photopolymerised around carbon nanotubes, a method for production and application thereof | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7991730B2 | Methods for similarity searching of chemical reactions | Physics | 3 | Active |
| US7881823B2 | Robotic positioning and orientation device and needle holder comprising one such device | Emerging Cross-Sectional Technologies | 3 | Active |
| US6861508B2 | Transcriptional intermediary factor-2 | Chemistry; Metallurgy | 2 | Expired |
| US7582875B2 | Monolithic active pixel dosimeter | Electricity | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.